Mana.bio
About:
Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.
Website: https://www.mana.bio
Top Investors: Andreessen Horowitz, Technion - Israel Institute of Technology, NFX, LionBird, Base4 Capital
Description:
Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.
Total Funding Amount:
$29.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2021-01-01
Founders:
Roy Nevo, Yogev Debbi
Number of Employees:
11-50
Last Funding Date:
2023-10-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai